Ethnicity and stroke risk in patients with atrial fibrillation

Heart

Volumn 99, Issue 15, 2013, Pages 1087-1092

  Mathur, Rohini ^a   Pollara, Elizabeth ^b   Hull, Sally ^a   Schofield, Peter ^b   Ashworth, Mark ^b   Robson, John ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

WARFARIN;

ADULT; AFRICAN CARIBBEAN; AGED; ARTICLE; ASIAN; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SOUTH ASIAN; UNITED KINGDOM;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; CROSS-SECTIONAL STUDIES; ETHNIC GROUPS; FEMALE; HUMANS; LOGISTIC MODELS; LONDON; MALE; MEDICAL RECORDS, PROBLEM-ORIENTED; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PREVALENCE; RISK ASSESSMENT; RISK FACTORS; STROKE; WARFARIN;

EID: 84880123856     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-303767     Document Type: Article

References (35)

1. Heeringa J, Van der Kuip DAM, Hofman A, etal. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur HeartJ 2006;27:949-53.
2. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
3. Lip GYH, Brechin CM, et al. The global burden of atrial fibrillation and stroke: a systematic review of the epidemiology of atrial fibrillation in regions outside North America and Europe. Chest 2012;142:1489-98.
4. Ball J, Carrington MJ, McMurray JJV, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol 2003;142: Published Online First: 1 February 2013. doi:10.1016/j.ijcard.2012.12.093
5. Gill PS, Calvert M, Davis R, et al. Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES). PLoS ONE 2011;6:e26710.
6. Lambert A, Burden F, Rouse A. prevalence of vascular disease related conditions amongst various cultural (ethnic) groups in Birmingham, UK. http://medweb4.bham. ac.uk/websites/key-health-data/2009/ch-11.htm (accessed 14 Mar 2013).
7. Stewart JA, Dundas R, Howard RS, et al. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ 1999;318:967-71. (Pubitemid 29189087)
8. Soliman EZ, Alonso A, Goff DC. Atrial fibrillation and ethnicity: the known, the unknown and the paradox. Fut Cardiol 2009;5:547-56.
9. Gunarathne A, Patel JV, Gammon B, et al. Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features. Stroke 2009;40:e415-423.
10. NICE. Atrial fibrillation-dabigatran etexilate: guidance. http://publications.nice.org. uk/dabigatran-etexilate-for-the-prevention-of- stroke-and-systemic-embolism-in-atrial-fibrillation-ta249 (accessed 31 Jan 2013).
11. NICE. CG36 Atrial fibrillation: full guideline. http://guidance.nice.org. uk/CG36/ Guidance/pdf/English (accessed 6 Dec 2010).
12. Camm AJ, Lip GYH, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-413.
13. Lip GYH, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 2010;137:263-72.
14. Olesen JB, Lip GYH, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ 2011;342:d124.
15. Stott D, Dewar R, Garratt C, et al. UK Consensus Conference on 'Approaching the comprehensive management of Atrial Fibrillation: Evolution or revolution?' 2012. http://www.rcpe.ac.uk/clinical-standards/standards/rcpe-af- consensus-statement-2012.pdf (accessed 7 Jul 2012).
16. Aguilar MI, Hart R, Pearce LA. Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev 2007;3: CD006186.
17. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-12. (Pubitemid 46722325)
18. Sandhu RK, Bakal JA, Ezekowitz JA, et al. Risk stratification schemes, anticoagulation use and outcomes: the risk-treatment paradox in patients with newly diagnosed non-valvular atrial fibrillation. Heart 2011;97:2046-50.
19. Majeed A, Moser K, Carroll K. Trends in the prevalence and management of atrial fibrillation in general practice in England and Wales, 1994-1998: analysis of data from the general practice research database. Heart 2001;86:284-8. (Pubitemid 32800076)
20. Holt TA, Hunter TD, Gunnarsson C, et al. Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey. Br J Gen Pract 2012;62:710-17.
21. Meschia JF, Merrill P, Soliman EZ, et al. Racial disparities in awareness and treatment of atrial fibrillation: the reasons for geographic and racial differences in Stroke (REGARDS) study. Stroke 2010;41:581-7.
22. STROBE. STROBE Statement: checklist of items that should be included in reports of observational studies. http://www.strobe-statement.org/ (accessed 14 Mar 2013).
23. QOF. GP Quality and Outcomes Framework 2011/12 On-line GP practice database NHS Information Centre. http://www.qof.ic.nhs.uk/ (accessed 14 Mar 2013).
24. Conway DSG, Lip GYH. Ethnicity in relation to atrial fibrillation and stroke (the West Birmingham Stroke Project). Am J Cardiol 2003;92:1476-9. (Pubitemid 37532578)
25. Schofield P, Saka O, Ashworth M. Ethnic differences in blood pressure monitoring and control in south east London. Br J Gen Pract 2011;61:190-6.
26. Mathur R, Badrick E, Boomla K, et al. Prescribing in general practice for people with coronary heart disease; equity by age, sex, ethnic group and deprivation. Ethn Health 2011;16:107-23.
27. Olesen JB, Torp-Pedersen C, Hansen ML, et al. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study. Thromb Haemost 2012;107:1172-9.
28. Lee S, Shafe ACE, Cowie MR. UK stroke incidence, mortality and cardiovascular risk management 1999-2008: time-trend analysis from the General Practice Research Database. BMJ Open 2011;1:e000269.
29. Niska R, Han B. Anticoagulation for patients with atrial fibrillation in ambulatory care settings. J Am Board Fam Med 2009;22:299-306.
30. Hylek EM, Evans-Molina C, Shea C, et al. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation. Circulation 2007;115:2689-96. (Pubitemid 46842784)
31. Darkow T, Vanderplas AM, Lew KH, et al. Treatment patterns and real-world effectiveness of warfarin in nonvalvular atrial fibrillation within a managed care system. Curr Med Res Opin 2005;21:1583-94. (Pubitemid 41509186)
32. Mant J, Hobbs FDR, Fletcher K, et al. Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 2007;370:493-503. (Pubitemid 47212371)
33. NHS Improvement. Atrial Fibrillation GRASP-AF audit tool-NHS Improvement website. http://www.improvement.nhs.uk/heart/HeartImprovementHome/ AtrialFibrillation/tabid/128/Default.aspx (accessed 31 Jan 2013).
34. CEG. Clinical Effectiveness Group-Blizard Institute, Queen Mary University of London. http://blizard.qmul.ac.uk/research-groups/253-clinical- effectiveness-group. html (accessed 31 Jan 2013).
35. Jacobs LG, Billett HH, Freeman K, et al. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study. Am J Geriatr Pharmacother 2009;7:159-66.